🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsWhen to hold at a dose vs continue titrating — clinical decision framework Page 2

When to hold at a dose vs continue titrating — clinical decision framework

Dr.ObesityLA Wed, Jun 3, 2026 at 10:00 PM 7 replies 311 viewsPage 2 of 2
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Jun 5, 2026 at 1:13 AM#6
Dr.ObesityLA said:
Four weeks is the pharmacokinetics, not caution.

PSA for titration users considering the 0.25mg starting dose: this dose is NOT intended for weight loss. It's a titration dose to let your body adjust. Don't be discouraged if you don't lose much in the first month.

The therapeutic dose for weight management starts at 1.7mg (semaglutide) or 5mg (tirzepatide). Be patient with the ramp-up.

18 13mike_mealprep, NicoleRaleigh, james_edin and 15 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Jun 5, 2026 at 12:07 PM#7

Following on from Dr.NateNeph — and this may be the naive question:

What the trials actually did with participants who could not tolerate a step, because that is the situation I am in and the protocol summaries skip it?

Last edited: Jun 5, 2026 at 2:07 PM
17 12Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 14 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Jun 5, 2026 at 11:01 PM#8
dave_SLC said:
PSA for titration users considering the 0.25mg starting dose: this dose is NOT intended for weight loss.

Dose escalation anxiety for titration: I was terrified to move from 0.5mg to 1.0mg based on horror stories in this forum. But my actual experience? Slightly more appetite suppression, zero additional side effects.

Remember that the people posting about terrible side effects are a biased sample. Most people titrate up without drama — they just don't post about it because it's uneventful.

Last edited: Jun 6, 2026 at 5:01 AM
16 11RunnerRach, TrialNerd_Beth, HPLC_Greg and 13 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Jun 6, 2026 at 9:54 AM#9

OP back with an update, since a thread like this is useless without one.

Update — I came back down one step, held for a month, then went up again and it was uneventful the second time. Same ladder, slower.

15 10chris_chi24, tampaLisa73, KarenAZ_mom and 12 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Jun 8, 2026 at 2:14 PM#10
JenPlateau said:
Dose escalation anxiety for titration: I was terrified to move from 0.5mg to 1.0mg based on horror stories in this forum.

Agreed on the arithmetic, with one condition: holding indefinitely at a dose that is not doing anything is not patience, it is a stall with a nice name. The distinction is whether appetite has changed at all at the current step.

Ask again with the specifics and you will get a better answer than this one.

17 17maria_elpaso, anders_CPH, Dr.NutriCornell and 14 others
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register